Posted By: The American Journal of Human Genetics, AJHG AJHG: What motivated you to start working on this project? JM: I’m really interested in the field of interventional genetics and the idea that, by understanding the genetic variant underlying a disease, we can begin to develop therapeutic interventions! AJHG: What about the paper/project most excites... Read More
Posted By: The American Journal of Human Genetics, AJHG AJHG: What motivated you to start working on this project? TS: Expanding from rare inborn errors of immunity to population-scale genomics has been a transformative experience for me. While single-gene disorders gave me a strong foundation in genetics and immunology, I was particularly motivated to explore... Read More
Posted By: The American Journal of Human Genetics, AJHG AJHG: What motivated you to start working on this project? WL: I started working on this project in 2021, shortly after finishing my master’s in Biostatistics at Yale. At the time, large-scale phenome-wide rare-variant association results from biobanks were just starting to emerge, giving us... Read More
Posted By: HGG Advances HGGA: What motivated you to start working on this project? RS: Questions surrounding psychiatric and community health have always been close to my heart. Before graduate school, I worked on an emergency room behavioral assessment team and volunteered as a crisis counselor, which helped me understand that it is impossible to... Read More
For Immediate Release: Saturday, October 24, 2026, 9:45 a.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Presented By: Nikita Marcou, BA, Johns Hopkins University School of Medicine Rockville, Md. – Acute myeloid leukemia (AML), the most common type of leukemia, has the lowest survival rate. A donor stem cell transplant is currently... Read More